They will also ask about your previous attempts to lose weight and why those did or didnt work
The wide distribution of the GLP-1R has allowed the study of semaglutide and liraglutide pharmacological protocols to improve metabolic diseases in several experimental models (26, 40, 4850)
Current professional guidance recommends individual risk assessmentasymptomatic, low-risk patients often continue therapy, while those with significant GI symptoms or higher aspiration risk may hold doses pre-op per team instructions
One of Hendersons patients described it this way: I woke up, and it seemed like I had on my glasses, and there was a smudge over the bottom half of the lens, but it didnt go away. Thats the most common pattern (called inferior altitudinal vision loss), but its not the only one
Uh, it's still an injection, it's still a weekly injection